HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Metabolic Disorders & Obesity

The intricate relationship between metabolic disorders & obesity plays a pivotal role in diabetes pathogenesis. Excess adiposity, particularly visceral fat accumulation, promotes insulin resistance and chronic inflammation, increasing the likelihood of type 2 diabetes. Dysregulated lipid metabolism and hormonal imbalances further exacerbate metabolic dysfunction, contributing to conditions such as metabolic syndrome and non-alcoholic fatty liver disease. Emerging research highlights the role of gut microbiota and genetic predisposition in metabolic health. Novel therapeutic strategies, including GLP-1 receptor agonists, bariatric surgery, and personalized nutrition plans, are proving effective in managing obesity-driven metabolic disorders. A multidisciplinary approach integrating pharmacotherapy, lifestyle interventions, and early screening is essential for preventing disease progression.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

University of Belize, Belize
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Teji S Dhami

Teji S Dhami

Boost your Health and Wellness, United States
Tags

Submit your abstract Today

Watsapp